S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Did You See These Trend Reversals? (Ad)pixel
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
Did You See These Trend Reversals? (Ad)pixel
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
What’s At Stake In April is Shocking (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Did You See These Trend Reversals? (Ad)pixel
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
Did You See These Trend Reversals? (Ad)pixel
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
What’s At Stake In April is Shocking (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Did You See These Trend Reversals? (Ad)pixel
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
Did You See These Trend Reversals? (Ad)pixel
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
What’s At Stake In April is Shocking (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Did You See These Trend Reversals? (Ad)pixel
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
Did You See These Trend Reversals? (Ad)pixel
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
What’s At Stake In April is Shocking (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
NASDAQ:YTEN

Yield10 Bioscience - YTEN Stock Forecast, Price & News

$2.76
+0.01 (+0.36%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.60
▼
$2.80
50-Day Range
$2.31
▼
$4.10
52-Week Range
$1.63
▼
$6.12
Volume
10,446 shs
Average Volume
78,035 shs
Market Capitalization
$14.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00

Yield10 Bioscience MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
334.8% Upside
$12.00 Price Target
Short Interest
Healthy
2.69% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.64) to ($0.80) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.64 out of 5 stars

Consumer Staples Sector

116th out of 138 stocks

Agricultural Production - Crops Industry

9th out of 11 stocks

See Top Rated MarketRank™ Stocks Here

YTEN stock logo

About Yield10 Bioscience (NASDAQ:YTEN) Stock

Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company was founded by Anthony J. Sinskey, Simon F. Williams, and Oliver P. Peoples in 1992 and is headquartered in Woburn, MA.

Receive YTEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter.

YTEN Stock News Headlines

March 28, 2023 | americanbankingnews.com
Yield10 Bioscience (NASDAQ:YTEN) & Limoneira (NASDAQ:LMNR) Financial Comparison
March 17, 2023 | finance.yahoo.com
Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2022 Earnings Call Transcript
April 2, 2023 | Investorplace Media (Ad)
5 Hypergrowth Stocks to Buy Now
Luke Lango has found 14 stocks that have gone up over 1,000%. Now he’s named his top stocks for 2023. Just click to claim your copy. pixel
March 16, 2023 | markets.businessinsider.com
Analysts Offer Insights on Materials Companies: Franco-Nevada (FNV) and Yield10 Bioscience (YTEN)
March 15, 2023 | finanznachrichten.de
Yield10 Bioscience, Inc.: Yield10 Bioscience Announces Fourth Quarter and Full Year 2022 Financial Results
March 15, 2023 | msn.com
Yield10 Bioscience's Return On Capital Employed Insights
March 15, 2023 | markets.businessinsider.com
Lake Street Reaffirms Their Buy Rating on Yield10 Bioscience (YTEN)
March 15, 2023 | finance.yahoo.com
Q4 2022 Yield10 Bioscience Inc Earnings Call
April 2, 2023 | Vantage Point (Ad)
Did You See These Trend Reversals?
Get ready for a potentially shocking and unprecedented announcement from the Fed meeting on May 3rd. This could cause many retail and industry traders to resort to drastic measures. One swift stroke could make popular assets plummet, BUT… there’s a straightforward solution to act now to protect your family and wealth. pixel
March 14, 2023 | finance.yahoo.com
Yield10 Bioscience Announces Fourth Quarter and Full Year 2022 Financial Results
March 13, 2023 | msn.com
A Preview Of Yield10 Bioscience's Earnings
March 8, 2023 | finance.yahoo.com
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2022 Financial Results and Host a Conference Call on Tuesday, March 14, 2023
March 2, 2023 | msn.com
Why Yield10 Bioscience Stock Is Taking Off Thursday
February 21, 2023 | finance.yahoo.com
Yield10 Bioscience Announces Key Advancements in the Development of Herbicide Tolerant Camelina Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market
February 16, 2023 | finance.yahoo.com
Yield10 Bioscience to Present at the Third Annual Winter Wonderland - Best Ideas 2023 Virtual Conference on February 21, 2023
January 13, 2023 | marketwatch.com
Yield10 Bioscience Shares Decline 8.3%, Paring Back Gains on Potential Biofuel Partnership
January 13, 2023 | benzinga.com
Short Volatility Alert: Yield10 Bioscience
January 12, 2023 | markets.businessinsider.com
Lake Street Keeps Their Buy Rating on Yield10 Bioscience (YTEN)
January 11, 2023 | marketwatch.com
Yield10 Bioscience Stock Up 53% on Potential Biofuel Partnership with Mitsubishi
January 11, 2023 | finance.yahoo.com
Yield10 Bioscience and Mitsubishi Corporation Sign MOU to Evaluate the Establishment of a Partnership to Supply, Offtake and Market Camelina as a Feedstock Oil for Biofuel
November 21, 2022 | finance.yahoo.com
Yield10 Bioscience to Present at the CG AgriFood Tech Innovation Virtual Forum
November 21, 2022 | finance.yahoo.com
Yield10 Bioscience to Present at the CG AgriFood Tech Innovation Virtual Forum
November 17, 2022 | finance.yahoo.com
Yield10 Bioscience Third Quarter 2022 Earnings: Misses Expectations
November 15, 2022 | finance.yahoo.com
Yield10 Bioscience Announces Third Quarter 2022 Financial Results
November 15, 2022 | seekingalpha.com
Yield10 Bioscience, Inc. (YTEN) Q3 2022 Earnings Call Transcript
November 10, 2022 | finance.yahoo.com
Yield10 Bioscience Begins Winter 2022/2023 Field Test and Seed Production Program
November 7, 2022 | finance.yahoo.com
Yield10 Bioscience to Announce Third Quarter 2022 Financial Results and Host a Conference Call on Monday, November 14, 2022
See More Headlines
Receive YTEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter.

YTEN Company Calendar

Last Earnings
11/09/2021
Today
4/02/2023
Next Earnings (Estimated)
5/10/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Agricultural production - crops
Sub-Industry
N/A
Sector
Consumer Staples
Current Symbol
NASDAQ:YTEN
CUSIP
N/A
CIK
1121702
Web
www.yield10bio.com
Phone
(617) 583-1700
Fax
617-583-1768
Employees
29
Year Founded
1992

Price Target and Rating

Average Stock Price Forecast
$12.00
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+334.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($2.76)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-13,570,000.00
Net Margins
-3,014.67%
Pretax Margin
-2,980.00%
Return on Equity
-154.59%
Return on Assets
-106.96%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.12
Quick Ratio
3.12

Sales & Book Value

Annual Sales
$450,000.00
Price / Sales
31.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.89 per share
Price / Book
3.10

Miscellaneous

Outstanding Shares
5,074,000
Free Float
4,805,000
Market Cap
$14.00 million
Optionable
Not Optionable
Beta
1.75

Social Links


Key Executives

  • Oliver P. Peoples
    President, Chief Executive Officer & Director
  • Charles B. HaaserCharles B. Haaser
    Chief Accounting Officer, Treasurer & VP-Finance
  • Kristi D. Snell
    Chief Science Officer & Vice President-Research
  • Nicholas Renegar
    Director-Business Analytics & Operations
  • Lynne H. Brum
    Secretary, VP-Planning & Communications

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













YTEN Stock - Frequently Asked Questions

Should I buy or sell Yield10 Bioscience stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Yield10 Bioscience in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" YTEN shares.
View YTEN analyst ratings or view top-rated stocks.

What is Yield10 Bioscience's stock price forecast for 2023?

2 analysts have issued 1-year target prices for Yield10 Bioscience's shares. Their YTEN share price forecasts range from $12.00 to $12.00. On average, they anticipate the company's share price to reach $12.00 in the next year. This suggests a possible upside of 334.8% from the stock's current price.
View analysts price targets for YTEN or view top-rated stocks among Wall Street analysts.

How have YTEN shares performed in 2023?

Yield10 Bioscience's stock was trading at $1.6695 at the beginning of the year. Since then, YTEN shares have increased by 65.3% and is now trading at $2.76.
View the best growth stocks for 2023 here.

When is Yield10 Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023.
View our YTEN earnings forecast.

How were Yield10 Bioscience's earnings last quarter?

Yield10 Bioscience, Inc. (NASDAQ:YTEN) posted its quarterly earnings results on Tuesday, November, 9th. The specialty chemicals company reported ($0.49) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.65) by $0.16. The specialty chemicals company had revenue of $0.09 million for the quarter, compared to analyst estimates of $0.22 million. Yield10 Bioscience had a negative net margin of 3,014.67% and a negative trailing twelve-month return on equity of 154.59%. During the same quarter in the previous year, the firm posted ($0.87) earnings per share.

When did Yield10 Bioscience's stock split?

Shares of Yield10 Bioscience reverse split before market open on Thursday, January 16th 2020. The 1-40 reverse split was announced on Wednesday, January 15th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 15th 2020. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of Yield10 Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Yield10 Bioscience investors own include KushCo (KSHB), OPKO Health (OPK), T2 Biosystems (TTOO), FuelCell Energy (FCEL), TherapeuticsMD (TXMD), Viking Therapeutics (VKTX), Rigel Pharmaceuticals (RIGL), Advanced Micro Devices (AMD).

What is Yield10 Bioscience's stock symbol?

Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN."

How do I buy shares of Yield10 Bioscience?

Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Yield10 Bioscience's stock price today?

One share of YTEN stock can currently be purchased for approximately $2.76.

How much money does Yield10 Bioscience make?

Yield10 Bioscience (NASDAQ:YTEN) has a market capitalization of $14.00 million and generates $450,000.00 in revenue each year. The specialty chemicals company earns $-13,570,000.00 in net income (profit) each year or ($2.76) on an earnings per share basis.

How can I contact Yield10 Bioscience?

Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The official website for the company is www.yield10bio.com. The specialty chemicals company can be reached via phone at (617) 583-1700, via email at brets@coreir.com, or via fax at 617-583-1768.

This page (NASDAQ:YTEN) was last updated on 4/2/2023 by MarketBeat.com Staff